These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 12232845)

  • 21. Trends in perimortal conditions and mortality rates among HIV-infected patients.
    Hooshyar D; Hanson DL; Wolfe M; Selik RM; Buskin SE; McNaghten AD
    AIDS; 2007 Oct; 21(15):2093-100. PubMed ID: 17885300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changing HIV infection-related mortality rate and causes of death among persons with HIV infection before and after the introduction of highly active antiretroviral therapy: analysis of all HIV-related deaths in Barbados, 1997-2005.
    Kumar A; Kilaru KR; Forde S; Roach TC
    J Int Assoc Physicians AIDS Care (Chic); 2006 Sep; 5(3):109-14. PubMed ID: 16928879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART.
    Jarrin I; Lumbreras B; Ferreros I; Pérez-Hoyos S; Hurtado I; Hernández-Aguado I
    Int J Epidemiol; 2007 Feb; 36(1):187-94. PubMed ID: 17085455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of HIV infection on age and cause of death for persons with hemophilia A in the United States.
    Chorba TL; Holman RC; Clarke MJ; Evatt BL
    Am J Hematol; 2001 Apr; 66(4):229-40. PubMed ID: 11279632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
    Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F;
    Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
    Martínez E; Milinkovic A; Buira E; de Lazzari E; León A; Larrousse M; Loncá M; Laguno M; Blanco JL; Mallolas J; García F; Miró JM; Gatell JM
    HIV Med; 2007 May; 8(4):251-8. PubMed ID: 17461853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in mortality following HIV and AIDS and estimation of the number of people living with diagnosed HIV/AIDS in Australia, 1981-2003.
    Nakhaee F; Black D; Wand H; McDonald A; Law M
    Sex Health; 2009 Jun; 6(2):129-34. PubMed ID: 19457292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
    Viani RM; Araneta MR; Deville JG; Spector SA
    Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AIDS mortality before and after the introduction of highly active antiretroviral therapy: does it vary with socioeconomic group in a country with a National Health System?
    Borrell C; Rodríguez-Sanz M; Pasarín MI; Brugal MT; García-de-Olalla P; Marí-Dell'Olmo M; Caylà J
    Eur J Public Health; 2006 Dec; 16(6):601-8. PubMed ID: 16698886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-AIDS-defining cancers: should antiretroviral therapy be initiated earlier?
    Cinti SK; Gandhi T; Riddell J
    AIDS Read; 2008 Jan; 18(1):18-20, 26-32. PubMed ID: 18240449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study.
    Hessol NA; Kalinowski A; Benning L; Mullen J; Young M; Palella F; Anastos K; Detels R; Cohen MH
    Clin Infect Dis; 2007 Jan; 44(2):287-94. PubMed ID: 17173233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Causes of the decline in AIDS deaths, United States, 1995-2002: prevention, treatment or both?
    Holtgrave DR
    Int J STD AIDS; 2005 Dec; 16(12):777-81. PubMed ID: 16336756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.
    Etard JF; Ndiaye I; Thierry-Mieg M; Guèye NF; Guèye PM; Lanièce I; Dieng AB; Diouf A; Laurent C; Mboup S; Sow PS; Delaporte E
    AIDS; 2006 May; 20(8):1181-9. PubMed ID: 16691070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
    Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
    HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
    Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
    Cheung MC; Pantanowitz L; Dezube BJ
    Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome.
    Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK; Tonascia J
    Clin Infect Dis; 2003 Nov; 37(10):1365-73. PubMed ID: 14583871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombotic microangiopathy in patients with acquired immunodeficiency syndrome before and during the era of introduction of highly active antiretroviral therapy.
    Gervasoni C; Ridolfo AL; Vaccarezza M; Parravicini C; Vago L; Adorni F; Cappelletti A; d'Arminio Monforte A; Galli M
    Clin Infect Dis; 2002 Dec; 35(12):1534-40. PubMed ID: 12471574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Change in the survival of Cuban AIDS patients with tuberculosis in the Highly Active Antiretroviral Therapy (HAART) era].
    Reyes-Corcho A; Capo de Paz V; Díaz-Jidy M; Pérez-Avila J; Bouza-Jiménez Y
    Invest Clin; 2008 Sep; 49(3):309-20. PubMed ID: 18846772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The neuropathology of HIV infection in the era of highly active antiretroviral therapy].
    Vallat-Decouvelaere AV; Chrétien F; Lorin de la Grandmaison G; Carlier R; Force G; Gray F
    Ann Pathol; 2003 Oct; 23(5):408-23. PubMed ID: 14752384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.